Pfizer strengthens growth in vaccine & biologics segments through acquisition of Wyeth
Saturday, January 30, 2010 15:00 IST New York
Pfizer Inc. provided an update to its pipeline for the first time since the close of the acquisition of Wyeth in October, 2009. The new development pipeline, composed of assets